Glutathione Injection Dosage Chart: Where the Numbers Came From
Trace the figures back to their studies, in order, and see which question those studies were asking.
Glutathione is genuinely well studied. It is the body's principal intracellular antioxidant, PubMed carries over twelve thousand records mentioning it, and injected preparations have a registered clinical literature. All of that is true, and none of it answers the question most people arrive with.
Step 1: count the registered studies
ClinicalTrials.gov returns roughly 47 studies for glutathione injection. The phase distribution is that of a normal clinical portfolio: around eleven Phase 2, six Phase 3, five Phase 1, four Phase 4, plus several registered as not applicable.
At this point the field looks well covered.
Step 2: read the titles
This is the step that changes the picture. Chemotherapy-resistant ovarian cancer. Advanced hepatocellular carcinoma. Male infertility alongside a nutritional supplement combination.
The subject matter is oncology, hepatology and reproductive medicine. Titles mentioning skin, whitening, lightening or pigmentation number about two out of forty-seven.
Step 3: compare that with what is being searched
Search demand for glutathione injection is dominated by skin lightening. The registered literature is dominated by serious disease.
That is not a finding that cosmetic use was tested and failed. It is that the trials were asking different questions, so the evidence base people assume sits behind a cosmetic dosage figure largely does not exist.
Step 4: what a chart can honestly restate
A glutathione injection dosage chart can report what those studies administered, to whom, and by what route. Those are real figures from real protocols.
Moving them to a cosmetic purpose changes the indication, the population and usually the route in a single step, and a table shows none of the three. The honest versions name the study behind each number, which also makes the mismatch visible.
Why endogenous is not an argument
A molecule the body makes and regulates tightly is not therefore safe to add in arbitrary amounts by injection. If anything the opposite holds: tight endogenous regulation is a reason to want evidence for an exogenous dose, not a reason to skip it.